Edwards Lifesciences Corp. Stock
The price for the Edwards Lifesciences Corp. stock decreased slightly today. Compared to yesterday there is a change of -€0.120 (-0.150%).
With 31 Buy predictions and not a single Sell prediction Edwards Lifesciences Corp. is an absolute favorite of our community.
As a result the target price of 85 € shows a slightly positive potential of 9.54% compared to the current price of 77.6 € for Edwards Lifesciences Corp..
Criterium "Market Position" is seen as the biggest plus for Edwards Lifesciences Corp. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Edwards Lifesciences Corp. in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Edwards Lifesciences Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Edwards Lifesciences Corp. | -0.150% | 3.994% | -6.551% | 16.046% | 4.879% | 6.975% | -20.800% |
| Veeva Systems A | 4.470% | 12.758% | 18.349% | -16.958% | 4.073% | 11.465% | -30.847% |
| Boston Scientific | -0.210% | 5.269% | 7.511% | -51.748% | -47.598% | -7.473% | 12.220% |
| Waters Corp. | 1.100% | 7.579% | 7.121% | 47.589% | 7.383% | 33.333% | 4.142% |
Comments
Edwards Lifesciences (EW) is now covered by UBS Group AG. They set a "buy" rating and a $110.00 price target on the stock.
Show more
Ratings data for EW provided by MarketBeat
Edwards Lifesciences (EW) had its price target raised by JPMorgan Chase & Co. from $100.00 to $105.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for EW provided by MarketBeat
Edwards Lifesciences (EW) was upgraded by Leerink Partners from "market perform" to "outperform". They now have a $101.00 price target on the stock.
Show more
Ratings data for EW provided by MarketBeat